Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study - Wikidata - wikimedia - TriplyDB

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study

http://www.wikidata.org/entity/Q35010260

about

Gemcitabine-induced severe pulmonary toxicity.Carotid artery inflammation associated with gemcitabine-based therapy: a special report.

P2860

Q35641366-E313ED1E-3BA5-4E79-AF79-25D7E8A27CF8 Q38982287-76354849-D294-4D19-87B2-A7D36A1F3EE6

P2860

Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study

http://www.wikidata.org/entity/Q35010260

description

2002 nî lūn-bûn

@nan

2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@ast

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@en

type

label

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@ast

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@en

prefLabel

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@ast

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@en

P1433

Q35010260-E769A164-83AE-4EEA-BDB9-BB1EDCA8436E

P1476

Q35010260-E469D53F-FFAB-4834-AA4E-4CD5EFAB1D8F

P2093

Q35010260-19E2B0FC-0AC9-4B29-B343-C403F757EFC1

Q35010260-47F11C27-08AD-4206-BB9A-7AC3239913C2

Q35010260-6EC426C7-7766-4B4D-B66A-D9C769554ED5

Q35010260-B1FE7F68-8A7E-4F75-81CF-B7946D39968C

Q35010260-EF2A7A5F-D405-4627-AD50-AAE5DB75BB1D

Q35010260-F5FFBEAD-A711-423E-955B-494B8E8D287F

Q35010260-F87574A8-437C-4363-976F-958B4381CF1B

P2860

Q35010260-00A7181F-9C3E-4A96-B0E8-5D34E821921E

Q35010260-03A02BF3-C23B-44F1-96A0-9F64763E21A4

Q35010260-46D5C73A-9E58-4059-8E33-C906A3982F9D

Q35010260-4975A4D7-461A-42D5-A1FD-809ECE9A313B

Q35010260-600E5C35-EE4F-49D7-A738-847BF71235E2

Q35010260-93F8EC33-4D04-4F35-B4C0-065AF606962C

Q35010260-BF1C2BCC-250E-46BC-BDE3-52851230B1B2

Q35010260-C644BC06-A328-431C-9822-CDC9846F6E95

Q35010260-C78B3444-7B8C-409A-B305-2ECCD63BB0C5

Q35010260-DC26045C-BD18-4188-AA79-3F0BBD38BB87

P2888

Q35010260-A74A413A-9223-413D-AD78-D459D060949B

P304

Q35010260-E804FC6F-60CE-42D8-856D-DE65E50DF46B

P31

Q35010260-3CC4B51B-1AD1-41B2-9112-C777E56536DE

Q35010260-C79D1D1A-3719-4212-9928-E324ED8C1BCA

P356

Q35010260-0B25550D-614A-456E-8EAB-02D2884BF72B

P407

Q35010260-0B189527-91EF-47DD-B041-2039485CA51F

P433

Q35010260-435E4C69-81CF-40DD-9AC5-E83B4937B020

P478

Q35010260-6D004FB8-0982-4B7A-9DD3-17CF45B2956F

P577

Q35010260-110AE056-5367-4EF5-BD93-FF5A0B1AB264

Q35010260-C9A1D204-A3AC-40F3-9236-4897C4BE7C28

P5875

Q35010260-059A4A74-5CA7-4E24-A900-AB4F4CA9A2A3

P698

Q35010260-DEDC9C7B-4682-4E5B-8D29-DE8D1F97277E

P921

Q35010260-2CA3BDFD-B548-496F-BCA7-B481540F0F26

Q35010260-39647622-8F5D-4F8C-B4A0-8012781D37DF

Q35010260-541C2FE0-CB5F-44E6-B493-59C7A1B73063

Q35010260-8AC9E2F9-A887-4318-8A4F-EE9C0CEBD544

P932

Q35010260-137C3AC1-9B92-488F-B590-4A98D913F804

P356

P1433

British Journal of Cancer

P1476

Triplet chemotherapy with vino ...... lung cancer: a phase II study

@en

P2093

H Ohmatsu

http://www.w3.org/2001/XMLSchema#string

K Goto

http://www.w3.org/2001/XMLSchema#string

K Kubota

http://www.w3.org/2001/XMLSchema#string

R Kakinuma

http://www.w3.org/2001/XMLSchema#string

S Niho

http://www.w3.org/2001/XMLSchema#string

T Matsumoto

http://www.w3.org/2001/XMLSchema#string

Yutaka Nishiwaki

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer

Reporting results of cancer treatment

A phase II study with vinorelbine, gemcitabine and cisplatin in the treatment of patients with stage IIIb-IV non-small cell lung cancer (NSCLC).

Cisplatin, gemcitabine, and vinorelbine combination therapy in advanced non-small-cell lung cancer: a phase II randomized study of the Southern Italy Cooperative Oncology Group.

Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer.

Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer.

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature.

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.

P2888

P304

1360-1364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600658

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2002-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2002-12-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11014721

http://www.w3.org/2001/XMLSchema#string

P698

12454762

http://www.w3.org/2001/XMLSchema#string

P921

heterocyclic compound

non-small-cell lung carcinoma

P932

2376298

http://www.w3.org/2001/XMLSchema#string